A good shot!
"Leading vaccine developer and manufacturer Sanofi, which produces vaccines for diseases such as polio and influenza, will be investing in a new vaccine production centre in Singapore. Sanofi will invest €400 million and hire up to 200 locals over five years to create a state-of-the-art facility in Singapore that can produce multiple vaccines in one go.
When this facility comes online in 2026, together with the other companies like GSK Biologicals and Thermo Fisher Scientific, we will have the full capability for end-to-end production of almost all kinds of vaccines in Singapore, for ourselves and for the world. It will make us more resilient, physically and economically. It will also strengthen our position as part of the global vaccine value chain.
Companies like Sanofi and GSK invest here because they trust Singapore as a place where they can be sure that their ideas can be protected and executed on, and where we have dependable and skilled workers to deliver."
- Trade and Industry Minister Chan Chun Sing
No comments:
Post a Comment